Search All UT System Experts

Survival benefit of surgery after chemoradiotherapy for stage III (N0-2) non-small-cell lung cancer is dependent on pathologic nodal response

Ellis Ziel, Gregory Hermann, Neilayan Sen, Philip Bonomi, Michael J. Liptay, Mary Jo Fidler, Marta Batus, William H. Warren, Gary Chmielewski, David J. Sher

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Survival benefit of surgery after chemoradiotherapy for stage III (N0-2) non-small-cell lung cancer is dependent on pathologic nodal response'. Together they form a unique fingerprint.

Medicine & Life Sciences